Twitter - #AIprofs are negotiating .new realities of academic research | #MITTechReview
#AIprofs are negotiating .new realities of academic research | #MITTechReview https://t.co/M8bVSzwlNi "If .next big #AIbreakthrough comes not from a major company but from.scrappy academic lab" How might #RealisticVirtualEarthForSTEM @WorldUnivAndSch help https://t.co/8Kx5cOWGm5?
— WorldUnivandSch (@WorldUnivAndSch) August 11, 2026
https://x.com/WorldUnivAndSch/
https://x.com/Q_YogaMacFlower/
https://x.com/WUaSPress/
https://x.com/HarbinBook/
https://x.com/TheOpenBand/
AI professors are negotiating the new realities of academic research | MIT Technology Review
--
https://wiki.
- Scott GK MacLeod
Founder, President, CEO & Professor
at / of best STEAM CC licensed OCW, Wiki,
World University & School (WUaS)
- USPS US Post Office, PO Box 132, General Delivery, Canyon, CA 94516
1) non-profit 501(c)(3) Public Charity
building on CC-4 licensed MIT OCW in 7 languages -
http://
2) for profit general stock company WUaS Corporation in CA - http://
- wuas_ceo@
World University & School Innovation Research -
- http://scottmacleod.com
- https://twitter.com/
- https://x.com/Q_
- http://www.linkedin.com/in/
- https://twitter.com/
- https://scott-macleod.
- https://
* * *
[Air-L] CFP: AoIR CDMX Preconference: In Defense of the Commons ~ Did you or any of you see this GREAT
Puffin : ... blog post
~ https://goo.gl/maps/
Scott MacLeod's
Naked Harbin Ethnography:
Hippies, Warm Pools, Counterculture, Clothing-Optionality & Virtual Harbin
by Scott GK MacLeod
sgkmacleod@
Foreword by Nelson H.H. Graburn
UC Berkeley Professor Emeritus of Sociocultural Anthropology
http://www.scottmacleod.com/
Academic Press at World University and School
http://
Sandia Mountain Wilderness, NM: M 8/10/26 Recording @WorldUnivAndSch @WUaSPress #WUaSGermany #
https://
https://scott-macleod.
--
https://wiki.
- Scott GK MacLeod
Founder, President, CEO & Professor
at / of best STEAM CC licensed OCW, Wiki,
World University & School (WUaS)
- USPS US Post Office, PO Box 132, General Delivery, Canyon, CA 94516
1) non-profit 501(c)(3) Public Charity
building on CC-4 licensed MIT OCW in 7 languages -
http://
2) for profit general stock company WUaS Corporation in CA - http://
- wuas_ceo@
World University & School Innovation Research -
- http://scottmacleod.com
- https://twitter.com/
- https://x.com/Q_
- http://www.linkedin.com/in/
- https://twitter.com/
- https://scott-macleod.
- https://
--
*
| Mon, Aug 10, 10:13 AM (1 day ago) | |||
| ||||
CFP / Announcement: Pre Conference workshop: October 14, 2026
AoIR Preconference: In Defense of the Commons
Workshop facilitators: Zach McDowell, Fenwick McKelvey, Matt Vetter
As the Internet becomes just a data dump for the next AI model, there is a growing demand to articulate the loss and what's at stake over the Internet's future. We argue the commons is a critical, normative concept that needs to be reasserted.
Our workshop aims to build capacity in the development of new theory and practice through the The Critical Commons Research Network (CCRN), an international research collective focused on examining the sharing of digital public knowledge through infrastructural, political-economic, policy lenses, and other critical approaches. This network connects researchers, creating opportunities for mentorship and collaboration around the (digital) commons.
The workshop aims to:
Coordinate research on Internet commons and other shared services online, including Wikipedia, the Creative Commons, open AI models, and emerging hardware or peer-to-peer server collectives;
Advance new theories of the commons as a normative concept for internet studies;
Advocate for alternative forms of resistance against new enclosures of the commons through the Critical Commons Network.
A key function of the preconference is to coordinate researchers addressing the loss and threats to current Internet commons.
We aim to gather 20 to 30 researchers working along themes around the commons for a focused workshop articulating a plan for the network and to coordinate global research on commons theory and practice. We invite participants to submit a brief biography, description of their research project, and relevant publications.
The half-day workshop will be organized around three 60-minute thematic discussions developed from participant responses. Selected participants will be invited to give brief lightning talks to animate discussion. We anticipate themes to include:
Wikipedia: Fondly known as “the last best place on the Internet,” Wikipedia was founded on the utopian promise of a decentralized, collaborative, and nonproprietary model for creating and sharing “the sum of all human knowledge." Wikipedia remains a shining example of the digital “commons” — repositories of knowledge and information that have become infrastructural layers that support the Internet as we know it.
The future of free, libre, and open source collaboration: Beyond Wikipedia and its sister Wikimedia projects, the digital commons also includes open-source software projects (Debian, Pubpub), shadow libraries that circulate publicly funded research, and interoperable interfaces (such as RSS feeds and APIs). These institutional mechanisms for content, whether knowledge, data, multimedia, or code, eschew exclusive traditional property rights in favor of social governance, harnessing diverse, non-market motivations to create shared public goods.
AI Commons: AI drives new forms of extraction and enclosure of the commons through large language models (LLMs) that repurpose volunteer labor and open data in ways that may undermine the sustainability of the projects themselves. Open models, distributed model interfaces, and agentic-human collaborations function as both an alternative and a threat to growing empires of AI. Can open AI actually mitigate these negative externalities for the commons?
Theory and application of “traditional” commons systems (forestry, fisheries, etc) applying towards digital systems.
The discussions will be recorded and collected as a report and included in a forthcoming special issue in communication +1. Whenever possible we will attribute contributions to participants, but participants should expect their contributions to inform these outputs.
We encourage critical engagement with commons and commons theory. The ideal of the commons as an open, equitable, and self-regulating space exists under constant pressure, for many reasons. Internally, these projects are not the "mythical egalitarian space" they are often described as. They are characterized by power asymmetries, systemic biases, and complex bureaucracies that can exclude newcomers and marginalized communities who may wish to negotiate and challenge established norms.
Half-day for short workshopping to ensure there is time for networking activities.
Please submit by September 15th (earlier the better):
Your name and affiliation;
A 250 biography and/or description of your research program;
A 250-word interest statement on your idea that you’d like to develop and discuss
Participants will be selected through a peer-review, and announced soon thereafter.
The To unsubscribe send an email to air-l-leave@lists.aoir.org mailing list
is provided by the Association of Internet Researchers http://aoir.org
Subscribe, change options or unsubscribe at:
Join the Association of Internet Researchers:
http://www.aoir.org/
* * *
Stanford Medicine - ENT Experts Up Close- Latest Advances in Rhinology and Sinus Surgery, Tue August 11, 2026
Asked Gemini / AI Mode a related question to the one I asked in registration -
What might be an emerging OSK drug, or a variety of them, that could actually age reverse what I'm calling my eustation tube dysfunction in my right ear or water wound that started in a Yale swimming program, I posit, in the late 1960s and causes discomfort. I'd like to reverse it with age reversing OSK gene drug therapies if some might emerge even in 10 or 20 years. What are some possible possibilities here?
While OSK (Oct4, Sox2, Klf4) and epigenetic reprogramming are gaining significant traction for central nervous system tissues like the optic nerve, applying these therapies to address long-standing Eustachian tube dysfunction (ETD) or chronic middle/inner ear liquid retention introduces unique structural and biological hurdles.
The Eustachian tube itself is primarily composed of respiratory-type mucosal epithelium, smooth muscle, cartilage, and underlying connective tissue rather than neural cells. Reversing decades-old physical or inflammatory changes in these tissues via OSK gene therapies will likely take time to emerge.
Several potential avenues, mechanisms, and delivery models could develop over the next 10 to 20 years for ear conditions:
Local OSK/mRNA Transfection via Intratympanic Micro-Injections Instead of system-wide gene therapy, future therapies might deliver transient OSK mRNA encapsulated in lipid nanoparticles directly into the middle ear space via a minor transtympanic procedure (similar to routine ear tube placement). This localized exposure could reprogram the aged or chronically inflamed mucosal lining of the Eustachian tube without systemic side effects, resetting tissue inflammation, restoring lost cilia function, and improving natural fluid drainage.
Epigenetic Rejuvenation of Mucociliary Clearance Eustachian tube health depends heavily on tiny hair-like structures (cilia) sweeping fluid out into the nasopharynx. Over time or following swimming-related chronic inflammation, damaged or Senescent (aging) epithelial cells lose this sweeping action. Delivering partial reprogramming factors (such as modified OSK protocols or small-molecule OSK mimetic drugs) specifically targeting mucociliary precursor cells could regenerate healthy, fully functional ciliated epithelium.
Targeting Auditory Neuro-Somatic Pathways If chronic fluid retention or past mechanical trauma has led to secondary tissue stiffness, micro-scarring, or localized nerve hypersensitivity around the tensor veli palatini muscle (which mechanically opens the tube), vector-based gene therapies using specialized viral capsids (AAVs) could target the surrounding neuromuscular junction. Epigenetic rejuvenation of these specific neuromuscular tissues could restore the dynamic opening and closing mechanics of the tube during swallowing or yawning.
AAV-Mediated Regeneration of Surrounding Connective Tissue Chronic low-grade fluid accumulation can cause deep structural remodeling in the cartilage matrix supporting the Eustachian tube. Long-term developmental pipelines exploring OSK therapies packaged in specialized biomaterial hydrogels could be placed directly adjacent to the cartilage. Over weeks, controlled expression of OSK factors could reverse cartilage degradation and restore the structural elasticity required for proper pressure equalization.
Also asked AI Mode -
- Blocked Passages: Bone shape and swollen tissue block your sinus openings.
- Bad Bacteria: Germs and fungus live in the mucus and cause infections.
- Allergy Triggers: Your immune system reacts strongly to pollen and dust.
- Better Healing: Gene drugs could help repair damaged tissue inside the nose.
- Smart Immunity: Therapies might calm down the overactive immune response.
- Tissue Repair: New cells could grow healthy lining in your sinuses.
- Acutelung/Infectious Sinusitis: Caused by sudden viral or bacterial infections; diet cannot replace antibiotics or decongestants.
- Chronic Rhinosinusitis (CRS): Involves long-term mucosal inflammation; a healthy diet may modestly reduce overall inflammatory markers, but it does not fix underlying structural issues like deviated septa. [1]
- Allergic Sinusitis: Triggered by environmental allergens; anti-inflammatory plant foods can support general immune function, but specific food or environmental triggers must be managed directly.
- Nasal Polyps/Aspirin-Exacerbated Respiratory Disease: Some individuals react to high-salicylate foods (which can include certain legumes and fruits), meaning a generic high-legume diet could potentially aggravate symptoms for specific sub-types rather than cure them. [1]
Sandia Mountain Wilderness, NM: M 8/10/26 Recording @WorldUnivAndSch @WUaSPress #WUaSGermany #
https://
https://scott-macleod.
https://stanfordhealthcare.
- Scott GK MacLeod
Founder, President, CEO & Professor
at / of best STEAM CC licensed OCW, Wiki,
World University & School (WUaS)
- USPS US Post Office, PO Box 132, General Delivery, Canyon, CA 94516
1) non-profit 501(c)(3) Public Charity
building on CC-4 licensed MIT OCW in 7 languages -
http://
2) for profit general stock company WUaS Corporation in CA - http://
- wuas_ceo@
https://wiki.
World University & School Innovation Research -
- http://scottmacleod.com
- https://twitter.com/
- https://x.com/Q_
- http://www.linkedin.com/in/
- https://twitter.com/
- https://scott-macleod.
- https://
* * *
Turn Biotechnologies' ERA platform uses mRNA and lipid nanoparticles to transiently deliver reprogramming factors for skin and immune rejuvenation without using viral vectors.
Rejuvenate Bio injects systemic AAV-based OSK therapies into the bloodstream to reverse widespread age-related diseases like heart failure and whole-body frailty.
Retro Biosciences directs AAV-delivered epigenetic reprogramming factors into highly specific peripheral tissues to treat osteoarthritis and age-related hearing loss.
Altos Labs engineers customized transcription factors and small-molecule alternatives to standard OSK to treat broad metabolic and neurodegenerative conditions.
Ex vivo cellular reprogramming extracts patient cells, resets their epigenome safely in a lab environment, and reinfuses them to cure blood or brain disorders.
* * *
Claudia, Thanks - at MIT - for connecting on LinkedIN Tu 8/11/26 & greetings from World Univ & Sch building on MIT OCW in 7 languages +
Claudia, Thanks so much for connecting on https://www.linkedin.com/in/
Monday, August 10, 2026
Sandia Mountain Wilderness, NM: M 8/10/26 Recording @WorldUnivAndSch @WUaSPress #WUaSGermany #
https://
https://scott-macleod.
Best regards, Scott (#ScottGKMacLeod, President, CEO, Founder and Professor at free-to-students' 1st wing) -http://
--
https://wiki.
- Scott GK MacLeod
Founder, President, CEO & Professor
at / of best STEAM CC licensed OCW, Wiki,
World University & School (WUaS)
- USPS US Post Office, PO Box 132, General Delivery, Canyon, CA 94516
1) non-profit 501(c)(3) Public Charity
building on CC-4 licensed MIT OCW in 7 languages -
http://
2) for profit general stock company WUaS Corporation in CA - http://
- wuas_ceo@
World University & School Innovation Research -
- http://scottmacleod.com
- https://twitter.com/
- https://x.com/Q_
- http://www.linkedin.com/in/
- https://twitter.com/
- https://scott-macleod.
- https://
*
_-_cropped.jpg?utm_source=commons.wikimedia.org&utm_campaign=index&utm_content=thumbnail_unscaled&_=20180812142057)
_-_cropped.jpg?utm_source=commons.wikimedia.org&utm_campaign=index&utm_content=thumbnail_unscaled&_=20190922205623)
https://commons.wikimedia.org/wiki/Bulbophyllum
https://commons.wikimedia.org/wiki/Category:Bulbophyllum
https://species.wikimedia.org/wiki/Bulbophyllum_bicolor
https://www.orchidspecies.com/orphotdir/bulbroxburg.jpg
https://www.orchidspecies.com/bulbroxburg.htm
....
Posts
![Bulbophyllum spp: Twitter - #AIprofs are negotiating .new realities of academic research | #MITTechReview * * * [Air-L] CFP: AoIR CDMX Preconference: In Defense of the Commons ~ Did you or any of you see this GREAT Creative Commons' Fireside Chat with its Founders * * * Stanford Medicine - ENT Experts Up Close- Latest Advances in Rhinology and Sinus Surgery, Tue August 11, 2026 * * * What are around five next likely OSK aging reversal gene drug therapies likely to go through clinical trials related to the ER 100 drug for glaucoma conditions, epigenetic reprogramming, but somehow also quite different? What are around five next likely OSK aging reversal gene drug therapies likely to go through clinical trials related to the ER 100 drug for glaucoma conditions, epigenetic reprogramming, but somehow also quite different? https://share.gemini.google/pxEACRi58KBE What are around five next likely OSK aging reversal gene drug therapies likely to go through clinical trials related to the ER 100 drug for glaucoma conditions, epigenetic reprogramming, but somehow also quite different from ER 100. What are the five next possible or likely OSK drugs to enter clinical trials? Turn Biotechnologies' ERA platform uses mRNA and lipid nanoparticles to transiently deliver reprogramming factors for skin and immune rejuvenation without using viral vectors. Rejuvenate Bio injects systemic AAV-based OSK therapies into the bloodstream to reverse widespread age-related diseases like heart failure and whole-body frailty. Retro Biosciences directs AAV-delivered epigenetic reprogramming factors into highly specific peripheral tissues to treat osteoarthritis and age-related hearing loss. Altos Labs engineers customized transcription factors and small-molecule alternatives to standard OSK to treat broad metabolic and neurodegenerative conditions. Ex vivo cellular reprogramming extracts patient cells, resets their epigenome safely in a lab environment, and reinfuses them to cure blood or brain disorders. https://share.gemini.google/pxEACRi58KBE * * * Claudia, Thanks - at MIT - for connecting on LinkedIN Tu 8/11/26 & greetings from World Univ & Sch building on MIT OCW in 7 languages +](https://upload.wikimedia.org/wikipedia/commons/8/8a/Bulbophyllum_affine_%2819698522320%29_-_cropped.jpg?utm_source=commons.wikimedia.org&utm_campaign=index&utm_content=thumbnail_unscaled&_=20190912202339){kind=link}
No comments:
Post a Comment